4.6 Article

Multicenter Diagnostic Evaluation of a Novel Coronavirus Antigen Lateral Flow Test among Symptomatic Individuals in Brazil and the United Kingdom

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

A prospective diagnostic evaluation of accuracy of self-taken and healthcare worker-taken swabs for rapid COVID-19 testing

Helen R. Savage et al.

Summary: This study compared the accuracy of self-taken and healthcare worker taken throat/nasal samples for diagnosing COVID-19 using RDTs. The results showed that self-taken samples are a feasible and accurate alternative to healthcare worker taken samples for RDT testing in diagnosing COVID-19.

PLOS ONE (2022)

Article Infectious Diseases

Performance of SARS-CoV-2 antigen testing in symptomatic and asymptomatic adults: a single-center evaluation

Stephanie L. Mitchell et al.

Summary: The study found that antigen testing performs well in symptomatic adults but poorly in asymptomatic patients. Testing within 5 days of symptom onset in symptomatic patients showed higher sensitivity. To improve accuracy, asymptomatic patients should consider using nucleic acid amplification tests.

BMC INFECTIOUS DISEASES (2021)

Article Infectious Diseases

Scaling up COVID-19 rapid antigen tests: promises and challenges

Rosanna W. Peeling et al.

Summary: WHO recommends antigen-detection rapid diagnostic tests (Ag-RDTs) with at least 80% sensitivity and 97% specificity for patients with symptoms consistent with COVID-19. Ag-RDTs may show high false negative rates after the acute phase, suggesting the need for a combination of molecular and serological tests. In low prevalence settings and situations where infection needs to be ruled out, Ag-RDTs with high negative predictive values can be used confidently, but high false positive rates in low prevalence areas require further confirmation.

LANCET INFECTIOUS DISEASES (2021)

Review Genetics & Heredity

Testing at scale during the COVID-19 pandemic

Tim R. Mercer et al.

Summary: The assembly and publication of the SARS-CoV-2 genome in January 2020 allowed for immediate development of tests and led to the largest global testing programme in history. Despite efforts to control the spread, widespread community transmission of the virus has become entrenched in many countries, necessitating population-scale testing to identify and isolate infected individuals. Testing plays a crucial role in the response to the COVID-19 pandemic and is likely to continue to be vital in public health.

NATURE REVIEWS GENETICS (2021)

Article Multidisciplinary Sciences

Limit of detection in different matrices of 19 commercially available rapid antigen tests for the detection of SARS-CoV-2

Ana Cubas-Atienzar et al.

Summary: In this study, an independent evaluation was conducted on the limit of detection (LOD) of 19 marketed Ag-RDTs, revealing that most tests performed well with direct culture supernatant but showed decreased sensitivity in Amies media. Additionally, after 7 days of storage at -80 degrees C, some tests exhibited reduced efficiency on stored dilutions of SARS-CoV-2.

SCIENTIFIC REPORTS (2021)

Article Health Care Sciences & Services

SARS-CoV-2 transmission risk from asymptomatic carriers: Results from a mass screening programme in Luxembourg

Paul Wilmes et al.

Summary: Luxembourg implemented a mass screening programme to accompany the lifting of COVID-19 lockdown measures, covering a significant portion of the population and identifying cases in various sectors and regions. Asymptomatic carriers pose a significant risk for transmission, emphasizing the importance of early testing and high participation rates.

LANCET REGIONAL HEALTH-EUROPE (2021)

Review Medicine, General & Internal

Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection

Jacqueline Dinnes et al.

Summary: Accurate and rapid diagnostic tests for SARS-CoV-2 infection are crucial for managing the COVID-19 pandemic. Point-of-care antigen and molecular tests can increase access to testing and expedite clinical and public health management decisions. Studies show that antigen tests have varying sensitivity, with higher accuracy in the first week of infection, and the efficacy of molecular tests depends on the specific brand used.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2021)

Article Biochemical Research Methods

Nextstrain: real-time tracking of pathogen evolution

James Hadfield et al.

BIOINFORMATICS (2018)